Kelly v. Nortel Networks Corp, 536 U.S. 956 (2002). · Go Syfert
Search
Kelly v. Nortel Networks Corp, 536 U.S. 956 (2002). Cases Citing This Book View Copy Cite
10 citation events (10 in the last 25 years) across 7 distinct courts.
Strongest positive: Pharmaceutical Research & Manufacturers of America v. Meadows (ca11, 2002-09-06)
Top citers, strongest first. 1 distinct citer. How cited ↗
cited Cited "see" Pharmaceutical Research & Manufacturers of America v. Meadows
11th Cir. · 2002 · signal: see · confidence high
See Pharmaceutical Research & Mfrs. of Am. v. Concannon, — U.S.-, 122 S.Ct. 2657 , 153 L.Ed.2d 833 (2002).
Retrieving the full opinion text from the archive…
Kelly
v.
Nortel Networks Corp
01-9927.
Supreme Court of the United States.
Jun 28, 2002.
536 U.S. 956
Published

536 U.S. 956

KELLY
v.
NORTEL NETWORKS CORP.

No. 01-9927.

Supreme Court of the United States.

June 28, 2002.

1

C. A. 1st Cir. Motions of petitioners for leave to proceed in forma pauperis denied. Petitioners are allowed until July 19, 2002, within which to pay the docketing fees required by Rule 38(a) and to submit petitions in compliance with Rule 33.1 of the Rules of this Court.